Sapacitabine / 151823-14-2

• Post Date:

  Aug 18,2016

• Expiry Date:

  Aug 18,2017

• Detailed Description:

  Cas No. :151823-14-2 Quantity: 0.1Kilograms
  Specs:In-house standard
  Payment Method: T/T
  Sapacitabine is a drug undergoing research for potential use in chemotherapy.Sapacitabine is an oral nucleoside analog prodrug that acts through a dual mechanism. The compound interferes with DNA synthesis by causing single-strand DNA breaks and induces arrest of the cell division cycle at G2 phase.
  Both sapacitabine and its major metabolite, CNDAC, have demonstrated potent anti-tumor activity in both blood and solid tumors in preclinical studies. In a liver metastatic mouse model, sapacitabine was shown to be superior to gemcitabine or 5-FU, two widely used nucleoside analogs, in delaying the onset and growth of liver metastasis.

• CAS Registry Number:

  151823-14-2

• Company:

  Shanghai Biopharmaleader Co.,Ltd     [ China ]        

• Contact:

  Brenda Xu

• Tel:

  021-50180596

• Fax:

  021-57758967

• Email:

  brenda@biopharmaleader.com